SOUTH
SAN FRANCISCO, Calif., May 1, 2023
/PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a
precision medicine oncology company committed to the discovery and
development of targeted therapeutics, announced its participation
in upcoming investor relations event(s).
RBC Capital Markets Global Healthcare Conference
Tuesday, May 16th, 2023 at
11:00 AM ET
- Fireside chat with Yujiro S.
Hata, Chief Executive Officer, hosted by Gregory Renza, Director and Senior Biotechnology
Research Analyst
Barclays Lunchtime Biotech Fireside Chat Series
Tuesday, May 23rd, 2023 at
12:00 PM ET
- Fireside chat with Yujiro S.
Hata, Chief Executive Officer, hosted by Peter Lawson, Managing Director and Equity
Research Analyst
A live audio webcast of conference events, as permitted by
conference host, will be available at the "Investors/News and
Events/Investor Calendar" section of the IDEAYA website at
https://ir.ideayabio.com/events and/or through the conference host.
A replay of available webcasts will be accessible for 30 days
following the live event.
About IDEAYA Biosciences
IDEAYA is a precision medicine oncology company committed to the
discovery and development of targeted therapeutics for patient
populations selected using molecular diagnostics. IDEAYA's approach
integrates capabilities in identifying and validating translational
biomarkers with drug discovery to select patient populations most
likely to benefit from its targeted therapies. IDEAYA is applying
its early research and drug discovery capabilities to synthetic
lethality – which represents an emerging class of precision
medicine targets.
Forward-Looking Statements
This press release contains forward-looking statements,
including, but not limited to, statements related to participation
in and/or presentation at certain investor relations events. IDEAYA
undertakes no obligation to update or revise any forward-looking
statements. For a further description of the risks and
uncertainties that could cause actual results to differ from those
expressed in these forward-looking statements, as well as risks
relating to the business of IDEAYA in general, see IDEAYA's recent
Annual Report on Form 10-K filed on March 7,
2023 and any current and periodic reports filed with the
U.S. Securities and Exchange Commission.
Investor and Media Contact
IDEAYA Biosciences
Paul Stone
Chief Financial Officer
investor@ideayabio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ideaya-biosciences-to-participate-in-upcoming-may-2023-investor-relations-event-301811423.html
SOURCE IDEAYA Biosciences, Inc.